Tag Archives: Pharmaceuticals
Global Guide on Pharmaceutical Market Pricing and Reimbursement
The issues of pricing and reimbursement play an important role in determining the likely commercial success of a pharmaceutical product in the marketplace. Following marketing authorisation, the pharmaceutical industry must successfully navigate...
The Global Pharmaceuticals Market to reach $971.1 billion by 2016
Pharmaceuticals: Global Industry Almanac is an essential resource for top-level data and analysis covering the Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive...
Patient Adherence, Communication and Engagement (PACE) Market Report
GBI Research, a leading business intelligence provider, has released its latest research, “Patient Adherence, Communication and Engagement (PACE) – Increased Investment and Adoption of New Digital Tools Enable Key Stakeholder Collaborations...
Diagnostic Testing in Physician Offices and Group Practices Supplier Shares and Sales Forecasts for Over 300 Tests
This report provides comprehensive analysis of the physician office/group practice diagnostics market, including its dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for...
Market and Product Forecasts: Targeted Cancer Therapies 2011-21
The targeted therapies class has fueled most of the recent rapid growth of the oncology market as a whole. In the next decade the market will become more fragmented as new targeted therapies are developed for niche populations. In addition...
Chinese Pharmaceutical GMP Regulations Latest Guide
MarketReportsOnline.com add “Latest Guide to Chinese Pharmaceutical GMP Regulations” The latest version of GMP follows up the main principles of WHO GMP, adopting advanced international experiences and also set forth the requirement of establish...
Parasitic Partnering 2007-2012
The Parasitic Partnering 2007-2012 report provides understanding and access to the parasitic partnering deals and agreements entered into by the worlds leading healthcare companies.
Trends in parasitic partnering deals
Top parasitic deals...
Angola Pharmaceuticals and Healthcare Report Q3 2012
Healthcare may not have been a major concern for Angola’s government – which has prioritised economic development over social development during the years since the civil war ended in 2002 – but with a general election scheduled for September...
Taiwan Pharmaceuticals and Healthcare Report Q3 2012
We do not expect Taiwan’s healthcare expenditure to reach the government’s target of 7.5% of GDP in the short to medium term – unless it increases medical service funding significantly, which is unlikely, given the downward pressure...
